| Hyperglycemia and outcome after myocardial infarction and cardiac surgery: so what? | |
| | |
MedLine Citation:
|
PMID: 16959754 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hyperglycemia is a frequent observation during acute illness such as myocardial infarction and after major surgery. The proportion of patients with hyperglycemia may be as high as 95% to 100% after cardiac surgery. This stress-induced hyperglycemia has a detrimental effect on outcome after myocardial infarction and cardiac surgery. Mortality may increase by a factor of 4, especially in non-diabetic patients. Control of hyperglycemia to normalize blood glucose is associated with a clear clinical benefit. This effect is most beneficial in nondiabetic patients with hyperglycemia. The exact target level of glycemia is still a matter of investigation, but normalization to values between 80 and 125 mg/dL is probably optimal. |
| | |
Authors:
|
Michael J Hiesmayr |
Related Documents
:
|
20036954 - Biomarkers of myocardial injury after cardiac arrest or myocardial ischemia. 7614304 - Need for sedation in a patient undergoing active compression--decompression cardiopulmo... 6465184 - Torsade de pointe. malignant cardiac arrhythmia induced by amantadine poisoning. 19752324 - Chest compression fraction determines survival in patients with out-of-hospital ventric... 15631334 - Heart failure in patients with chronic kidney disease. 22904 - Dose-dependent depression of cardiac function and metabolism by inhalation anesthetics ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in cardiothoracic and vascular anesthesia Volume: 10 ISSN: 1089-2532 ISO Abbreviation: Semin Cardiothorac Vasc Anesth Publication Date: 2006 Sep |
Date Detail:
|
Created Date: 2006-09-08 Completed Date: 2007-01-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9807630 Medline TA: Semin Cardiothorac Vasc Anesth Country: United States |
Other Details:
|
Languages: eng Pagination: 220-3 Citation Subset: IM |
Affiliation:
|
Department of Cardiac-Thoracic-Vascular Anaesthesia & Intensive Care Medicine, Medical University Vienna, Vienna, Austria. michael.hiesmayr@meduniwien.ac.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiac Surgical Procedures
/
adverse effects* Comorbidity Humans Hyperglycemia / drug therapy, epidemiology*, etiology Insulin / therapeutic use Myocardial Infarction / drug therapy, epidemiology* Thoracic Surgery |
| Chemical | |
Reg. No./Substance:
|
11061-68-0/Insulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acute insulin resistance in myocardial ischemia: causes and consequences.
Next Document: Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives...